Intimation Regarding Closure of Trading Window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Ltd has informed BSE that its trading window for insiders — including promoters, directors, key managerial personnel, designated persons, and their immediate relatives — will be closed from Wednesday, October 1, 2025 until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2025. The board meeting date to approve these Q2/H1 FY26 results has not been announced yet and will be communicated separately. This is a routine compliance filing under SEBI's Insider Trading Regulations and the company's internal code of conduct, not an actual insider trade disclosure.
This is a standard regulatory communication with no direct impact on share price or shareholders. Investors should note that upcoming Q2 results (due later in October) may be the next catalyst; the window closure signals that results are being prepared and likely to be announced within the next few weeks.